Jorge Martinez-Escribano
Overview
Explore the profile of Jorge Martinez-Escribano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez M, Martinez-Sanchez M, Lopez-Cubillana P, Fuster J, et al.
Oncoimmunology
. 2021 Oct;
10(1):1986943.
PMID: 34676148
NK and CD8 T cells are the main cytolytic effectors involved in innate and adaptive tumor immune surveillance, respectively. Although their educational pathways differ, similarities in their development and function...
2.
KIR+ CD8+ T Lymphocytes in Cancer Immunosurveillance and Patient Survival: Gene Expression Profiling
Gimeno L, Serrano-Lopez E, Campillo J, Canovas-Zapata M, Acuna O, Garcia-Cozar F, et al.
Cancers (Basel)
. 2020 Oct;
12(10).
PMID: 33076479
Killer-cell immunoglobulin-like receptors (KIR) are expressed by natural killer (NK) and effector T cells. Although KIR+ T cells accumulate in oncologic patients, their role in cancer immune response remains elusive....
3.
Godfrey L, Martinez-Escribano J, Roo E, Pino A, Anitua E
J Cosmet Dermatol
. 2020 Feb;
19(10):2552-2559.
PMID: 32045103
Background: Skin aging is characterized by moderate to severe wrinkles, laxity, roughness, and volume loss as a result of cutaneous atrophy and connective tissue degradation. Plasma rich in growth factor...
4.
Guillamon C, Gimeno L, Server G, Martinez-Sanchez M, Escudero J, Lopez-Cubillana P, et al.
Eur Urol Oncol
. 2019 Aug;
4(2):246-255.
PMID: 31411976
Background: Bladder cancer (BC) is highly immunogenic. Bacillus Calmette-Guérin (BCG) immunotherapy offers the best results in non-muscle-invasive BC (NMIBC). Natural killer cells (NKcs) play decisive roles in BCG-mediated immune response...
5.
Guillamon C, Martinez-Sanchez M, Gimeno L, Campillo J, Server-Pastor G, Martinez-Garcia J, et al.
Cancer Immunol Res
. 2019 Jun;
7(8):1307-1317.
PMID: 31239317
Therapies using NK cells (NKc) expanded/activated or stimulated with new immunostimulatory agents offer alternative opportunities for patients with recurrent/refractory tumors, but relevant biomarkers to guide the selection of patients are...
6.
Gimeno L, Martinez-Banaclocha H, Bernardo M, Bolarin J, Marin L, Lopez-Hernandez R, et al.
Cancers (Basel)
. 2019 Mar;
11(4).
PMID: 30925758
Background: Natural killer (NK) and CD8+ T cells are involved in the immune response against melanoma. C-Type lectin-like NK cell receptors are located in the Natural Killer Complex (NKC) region...
7.
Guillamon C, Martinez-Sanchez M, Gimeno L, Mrowiec A, Martinez-Garcia J, Server-Pastor G, et al.
Cancer Immunol Res
. 2018 Sep;
6(12):1537-1547.
PMID: 30242020
Natural killer cell (NKc)-based therapies offer promising outcomes in patients with tumors, but they could improve with appropriate selection of donors and optimization of methods to expand NKcs Education through...
8.
Barona Garcia L, de la Pena Moral J, Martinez-Escribano J, Ortiz-Reina S
J Cutan Med Surg
. 2018 Jul;
22(6):633-635.
PMID: 30003792
No abstract available.
9.
Pinero A, de Torre C, Martinez-Escribano J, Campillo J, Canteras M, Nicolas F
World J Surg
. 2011 Dec;
36(3):579-85.
PMID: 22205107
Background: There is some controversy in the literature regarding the possible prognostic value of cases of multiple lymphatic basin drainage (MLBD). The purpose of this work was to study the...
10.
de Torre C, Martinez-Escribano J
Exp Dermatol
. 2010 Jul;
19(8):e333-5.
PMID: 20653773
We have examined alterations in the cyclin-dependent kinase inhibitor 2A (CDKN2A) and cyclin-dependent kinase 4 (CDK4), major melanoma predisposing genes, in a Spanish melanoma-prone population comprising 61 patients from 45...